GoodRx Reports Fourth Quarter and Full Year 2025 Results
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Business Wire
Fourth Quarter and Full Year 2025 Revenue and Adjusted EBITDA Results In-line with Previous GuidancePharma Direct Revenue Beats Previous Outlook with Over 40% Year-Over-Year Growth for 2025 SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the fourth quarter and full year of 2025.Fourth Quarter 2025 HighlightsRevenue of $194.8 millionNet income of $5.4 million; Net income margin of 2.8%Adjusted Net Income1 of $29.0 million; Adjusted Net Income Margin1 of 14.9%Adjusted EBITDA1 of $65.0 million; Adjusted EBITDA Margin1 of 33.4%Net cash provided by operating activities of $32.9 millionFull Year 2025 HighlightsRevenue of $796.9 millionNet income of $30.4 million; Net income margin of 3.8%Adjusted Net Income1 of $126.1 million; Adjusted Net Income Margin1 of 15.8%Adjusted EBITDA1 of $270.5 million; Adjusted EBITDA Marg
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- GoodRx Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- GoodRx (GDRX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- GoodRx (GDRX) had its "outperform" rating reaffirmed by Leerink Partners.MarketBeat
- GoodRx Reports Fourth Quarter and Full Year 2025 Results [Yahoo! Finance]Yahoo! Finance
- GoodRx's (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8% [Yahoo! Finance]Yahoo! Finance
GDRX
Earnings
- 2/25/26 - Beat
GDRX
Sec Filings
- 2/26/26 - Form S-8
- 2/26/26 - Form 10-K
- 2/25/26 - Form 8-K
- GDRX's page on the SEC website